| Â | Normal Group | NTIS Group | Renal dysfunction Group | Combined Group |
|---|
OR (95% CI) | OR | 95% CI | P value | OR | 95% CI | P value | OR | 95% CI | P value |
|---|
Model 1 | 1 | 7.034 | 3.019–16.386 | < 0.001 | 4.155 | 1.889–9.141 | < 0.001 | 14.065 | 6.469–30.578 | < 0.001 |
Model 2 | 1 | 4.256 | 1.383–13.096 | 0.012 | 5.445 | 2.023–14.657 | 0.001 | 7.778 | 2.688–22.508 | < 0.001 |
Model 3 | 1 | 3.643 | 1.154–11.505 | 0.028 | 3.135 | 1.043–9.422 | 0.042 | 7.798 | 2.722–22.339 | < 0.001 |
- Model1: Adjusted for age, sex, smoking use, alcohol status, hypertension, diabetes, medical therapy (use of antiplatelet agents, β-Blockers, LLDs, ACEIs/ARBs, CCBs, and Diuretics), and BMI (for all patients)
- Model2: Adjusted for age, sex, smoking use, alcohol status, hypertension, diabetes, medical therapy, BMI, LVEF, Killip class, lg(NT-pro BNP), infarct type (NSTEMI vs STEMI), prior PCI or CABG and revascularization (PCI, CABG) (for all patients)
- Model3: Adjusted for age, sex, smoking use, alcohol status, hypertension, diabetes, medical therapy, BMI, LVEF, Killip class, lg(NT-pro BNP), infarct type (NSTEMI vs STEMI), prior PCI or CABG and revascularization (PCI, CABG), WBC, Hb, Alb, TC, TG, HDL-c, LDL-c, FPG and CRP (for all patients)
